John J. Boniface, Chief Scientific Officer at SERA PROGNOSTICS, INC. (SERA), sold 1,517 shares at $2.04 ($3K) on 2026-03-11, disclosed to the SEC on 2026-03-12.
Seasonal sale ($3k) by Chief Scientific Officer — this insider has traded SERA in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| SERA | SELL | 2025-11-12 | $20K | — | Filing → |
| SERA | SELL | 2025-09-12 | $4K | — | Filing → |
| SERA | SELL | 2025-08-11 | $18K | — | Filing → |